Feucht H H, Zöllner B, Laufs R
Institut für Medizinische Mikrobiologie und Immunologie, Universitätsklinikum Eppendorf, Hamburg, Germany.
J Virol Methods. 1995 Sep;55(1):105-10. doi: 10.1016/0166-0934(95)00049-z.
The detection of HCV-PCR amplification products by DNA enzyme immunoassay (DEIA) was compared with conventional hybridization carried out with a 32P-labelled oligonucleotide probe. The detection limit of both methods was shown to be between 100 pg and 1 ng of amplicon. All serum samples of 40 HCV-seropositive patients were positive after PCR in autoradiography, but only 38 with the DEIA technique (sensitivity 95%). There were no false-positive reactions by either method. The advantage of the DEIA method was the fast and non-radioactive detection of HCV amplicons. DEIA combines the specificity of the hybridization event with the speed of an ELISA procedure and is suitable for HCV-PCR.
采用DNA酶免疫测定法(DEIA)检测丙型肝炎病毒(HCV)-PCR扩增产物,并与使用32P标记的寡核苷酸探针进行的传统杂交方法进行比较。结果表明,两种方法的检测限均在100 pg至1 ng扩增子之间。40例HCV血清学阳性患者的所有血清样本经PCR后在放射自显影中均呈阳性,但采用DEIA技术时只有38例呈阳性(灵敏度95%)。两种方法均未出现假阳性反应。DEIA方法的优点是能够快速、非放射性地检测HCV扩增子。DEIA将杂交反应的特异性与ELISA程序的速度相结合,适用于HCV-PCR检测。